ScholarWorks@Gachon: Sym, Sun Jin

Detailed Information

Sym, Sun Jin (심선진)

College of Medicine (Department of Medicine)

Research Area

Tel 032-460-3209
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Chemotherapy:7||prognosis:4||Gastric cancer:4||Oxaliplatin:4||Prognosis:4||gastric cancer:3||chemotherapy:3||Radiation therapy:3||Moderately emetogenic chemotherapy:2||Cisplatin:2||Neoplasm:2||Supraclavicular lymph node:2||Gemcitabine:2||Irinotecan:2||Cervical cancer:2||trastuzumab:2||Quality of life:2||NonHodgkin lymphoma:2||Nonsmall cell lung cancer:2||Rectal cancer:2||HER2:2||S1:2||Secondline:2||Secondline chemotherapy:2||Capecitabine:2||Metastasis:2||Colorectal Cancer:1||Colorectal neoplasms:1||CrELfree paclitaxel:1||Crush cytology:1||Deep learning:1||Diffuse large B cell lymphoma:1||Diffuse large Bcell lymphoma:1||Diffuse large cell lymphoma:1||Docetaxel:1||Drug therapy:1||Elderly:1||Epidermal growth factor receptor:1||Epirubicin:1||Exercise:1||Expanded access program:1||Extranodal NK/Tcell lymphoma:1||Frozen sections:1||Gastrinoma:1||Gastrointestinal stromal tumor:1||Gefitinib:1||GenexolPM:1||Granisetron:1||HER2 gene amplification:1||Imatinib:1||Immunohistochemistry:1||Infusionrelated reaction:1||Keywords: Radiotherapy:1||Knowledgebased clinical decision support system (CDSS):1||Lactate dehydrogenase:1||Metabolic tumor volume:1||Modified FOLFIRINOX:1||Neuroendocrine tumors:1||Neurokinin1 receptor antagonists:1||Neuropathic pain:1||Neutropenia:1||Paclitaxel:1||Paget disease:1||Pain management:1||Pancreatic neoplasms:1||Pemetrexed:1||Polymorphism:1||Portal hypertension:1||Portal vein:1||Positronemission tomography:1||Prevalence:1||Prognostic factor:1||Ramucirumab:1||Randomised controlled trial:1||Receptor, epidermal growth factor:1||Risk factor:1||Rituximab:1||Small cell lung carcinoma:1||Squamous cell carcinoma antigen:1||Stenosis:1||Stent:1||Stomach cancer:1||Surger:1||Surgery:1||Survival:1||Thrombocytopenia:1||Transdermal granisetron:1||Trastuzumab:1||Tumor burden:1||Tumor volume:1||UGT1A1:1||Urethral clear cell carcinoma:1||Urinary bladder cancer:1||Vascular endothelial growth factor:1||ZollingerEllison syndrome:1||adverse event:1||and margetuximab plus pembrolizumab:1||antiinflammation:1||biomarkers:1||biosimilar:1||ctDNA:1||curcumin:1||diffuse large Bcell lymphoma:1||epsteinbarr virus:1||extramammary:1||gastric/gastroesophageal adenocarcinoma:1||glioblastoma multiforme:1||homing abilities:1||in vivo safety:1||lung tumors:1||mesenchymal stem cell:1||mesenchymal stem cells:1||metastasectomy:1||metastasis:1||metastatic colorectal cancer:1||muscle:1||mutual destruction:1||nanocarrier:1||nanodrug membrane conjugation:1||nasal type:1||neoplasm metastasis:1||nerve regeneration:1||neutrophiltolymphocyte ratio:1||nonHodgkin&apos:1||nonsmall cell lung cancer:1||nuclear diameter:1||paclitaxel:1||quality of life (QoL):1||ramucirumab:1||realworld data:1||s lymphoma:1||signet ring cell:1||survival:1||tumor inhibition:1||방광암:1||약물치료:1||Anal canal:1||전이:1||Anemia:1||Aprepitant:1||Artificial intelligence · Multidisciplinary care · Analysis effect.:1||Ascites:1||Belotecan:1||Biliary tract cancer:1||Bone marrow involvement:1||Brain metastases:1||Breakthrough cancer pain:1||CCRT:1||CD30:1||CD99:1||CINV:1||CTP6:1||Cancer:1||Capecitabine Acute Mesenteric Arterial Thrombosis 5FU:1||Carcinoma:1||Carcinoma, nonsmallcell lung:1||Central nervous system:1||Cervix cancer:1||Characteristics:1||Chemoradiation therapy:1||Chemotherapy recommendation:1||Chemotherapyinduced nausea and vomiting:1||Colorectal:1||

STATISTICS: Total View :4,136,558; Today View :4,237

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE